Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
bladder cancer
Pharma
Soon-Shiong's ImmunityBio bags FDA nod for bladder cancer drug
Patrick Soon-Shiong, a partial owner of the Lakers, touted Anktiva's ability to launch a "triangle offense" against tumors as a differentiator.
Angus Liu
Apr 22, 2024 10:40pm
With SK partnership, Ferring boosts long-term Adstiladrin supply
Apr 18, 2024 5:12pm
BMS, overshadowed by ADC rival, wins FDA nod in 1L bladder cancer
Mar 8, 2024 9:56am
Merck’s Keytruda delivers partial win in bladder cancer
Jan 26, 2024 10:20am
J&J's Balversa gets mixed label update in FDA approval conversion
Jan 22, 2024 11:12am
FDA gives Keytruda-Padcev bladder cancer combo a curtain call
Dec 18, 2023 10:53am